Chi Advisors LLC Ovid Therapeutics Inc. Transaction History

Chi Advisors LLC

$203 Million
Q3 2023

A detailed history of Chi Advisors LLC transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Chi Advisors LLC holds 864,822 shares of OVID stock, worth $899,414. This represents 1.64% of its overall portfolio holdings.

Number of Shares

864,822

Previous 864,822 -0.0%

Holding current value

$899,414

Previous $2.84 Million 17.07%

% of portfolio

1.64%

Previous 1.07%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$1.69 - $3.31 $20,168 - $39,501	11,934 Added 1.4%	864,822 $1.86 Million
Q1 2022 May 16, 2022	BUY	$2.65 - $3.49 $1.2 Million - $1.58 Million	452,888 Added 113.22%	852,888 $2.68 Million
Q4 2021 Feb 11, 2022	BUY	$3.13 - $3.73 $521,113 - $621,007	166,490 Added 71.3%	400,000 $1.28 Million
Q3 2021 Nov 15, 2021	BUY	$3.31 - $4.04 $49,650 - $60,600	15,000 Added 6.86%	233,510 $785,000
Q2 2021 Aug 11, 2021	SELL	$3.3 - $4.49 $95,700 - $130,210	-29,000 Reduced 11.72%	218,510 $854,000
Q1 2021 May 14, 2021	SELL	$2.42 - $4.47 $1.4 Million - $2.59 Million	-579,750 Reduced 70.08%	247,510 $995,000
Q4 2020 Feb 12, 2021	BUY	$2.28 - $6.84 $476,903 - $1.43 Million	209,168 Added 33.84%	827,260 $1.91 Million
Q3 2020 Nov 12, 2020	BUY	$5.39 - $8.24 $397,841 - $608,202	73,811 Added 13.56%	618,092 $3.55 Million
Q2 2020 Aug 12, 2020	SELL	$2.67 - $7.91 $758,632 - $2.25 Million	-284,132 Reduced 34.3%	544,281 $4.01 Million
Q1 2020 May 14, 2020	SELL	$2.03 - $4.35 $31,501 - $67,503	-15,518 Reduced 1.84%	828,413 $2.47 Million
Q4 2019 Feb 14, 2020	BUY	$2.08 - $5.06 $242,675 - $590,355	116,671 Added 16.04%	843,931 $3.5 Million
Q3 2019 Nov 12, 2019	BUY	$1.76 - $3.51 $1.28 Million - $2.55 Million	727,260 New	727,260 $2.36 Million

Others Institutions Holding OVID

# of Institutions

Shares Held

39M

Call Options Held

37.4K

Put Options Held

500

View Full List

About Ovid Therapeutics Inc.

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $73.2M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

More about OVID

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chi Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chi Advisors LLC with notifications on news.

Account